Counselors’ attitudes toward psychedelics and their use in therapy
Journal of Counseling & Development March 19, 2022 Benjamin Hearn, Michael D. Brubaker, George B. Richardson 46 citations
Abstract The ‘‘psychedelic renaissance’’ is generating new evidence for psychedelics’ potential to treat numerous mental and substance use disorders. In particular, the United States Food and Drug Administration is poised to approve psychedelic drugs 3,4 methylenedioxymethamphetamine (MDMA) and psilocybin for the use in psychedelic‐assisted therapy (PAT). This renaissance has led to substantial...